(Q37782559)

23 August 2017

title

MGMT immunoexpression in aggressive pituitary adenoma and carcinoma (English)

1 reference

23 August 2017

1 reference

Bernd Walter Scheithauer

2

object named as

Bernd Scheithauer

1 reference

23 August 2017

3

Kalman Kovacs

1 reference

23 August 2017

5

Luis V. Syro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740317

23 June 2024

author name string

Queenie Lau

1

1 reference

23 August 2017

Eva Horvath

4

1 reference

23 August 2017

Ricardo Lloyd

6

1 reference

23 August 2017

Bernd Scheithauer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740317

23 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20740317

23 June 2024

publication date

1 December 2010

1 reference

full work available at URL

23 August 2017

http://link.springer.com/content/pdf/10.1007/s11102-010-0249-0.pdf

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1007/S11102-010-0249-0

http://link.springer.com/article/10.1007/s11102-010-0249-0/fulltext.html

23 June 2024

1 reference

https://api.crossref.org/works/10.1007/S11102-010-0249-0

http://link.springer.com/content/pdf/10.1007/s11102-010-0249-0

23 June 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S11102-010-0249-0

23 June 2024

1 reference

23 August 2017

volume

13

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

367-379

1 reference

https://scigraph.springernature.com/pub.10.1007/s11102-010-0249-0

23 August 2017

exact match

0 references

cites work

Pituitary carcinoma: a review of the literature

1 reference

https://api.crossref.org/works/10.1007%2FS11102-010-0249-0

MGMT: its role in cancer aetiology and cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11102-010-0249-0

Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.

21 January 2018

1 reference

12 December 2020

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.

1 reference

12 December 2020

Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide

1 reference

12 December 2020

Molecular genetic markers as predictors of response to chemotherapy in gliomas

1 reference

12 December 2020

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

12 December 2020

Pituitary carcinoma presenting with multiple metastases: case report.

1 reference

12 December 2020

Long-term response of pituitary carcinoma to temozolomide. Report of two cases.

1 reference

12 December 2020

Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm

1 reference

12 December 2020

Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma

1 reference

12 December 2020

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

12 December 2020

High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.

1 reference

12 December 2020

Genetic association and functional studies of major polymorphic variants of MGMT.

1 reference

12 December 2020

Pituitary carcinoma: a clinicopathologic study of 15 cases

1 reference

12 December 2020

Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors

1 reference

12 December 2020

Immunohistochemical detection of the DNA repair enzyme O6-methylguanine-DNA methyltransferase in formalin-fixed, paraffin-embedded astrocytomas.

1 reference

12 December 2020

MGMT immunohistochemical expression and promoter methylation in human glioblastoma

1 reference

12 December 2020

Clinical review: Diagnosis and management of pituitary carcinomas.

1 reference

12 December 2020

Temozolomide: a novel treatment for pituitary carcinoma

1 reference

12 December 2020

Targeted modulation of MGMT: clinical implications

1 reference

12 December 2020

Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours.

1 reference

12 December 2020

O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitions

1 reference

12 December 2020

O(6)-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas: are progressive tumors potential candidates for temozolomide treatment?

1 reference

12 December 2020

Clinical relevance of MGMT in the treatment of cancer

1 reference

12 December 2020

Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.

1 reference

12 December 2020

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

1 reference

12 December 2020

MGMT hypermethylation: a prognostic foe, a predictive friend

1 reference

12 December 2020

Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors

1 reference

12 December 2020

Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms

1 reference

12 December 2020

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort

1 reference

12 December 2020

Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: Morphological findings

1 reference

12 December 2020

MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy

1 reference

12 December 2020

High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium

1 reference

12 December 2020

Treatment of Nelson's syndrome with temozolomide

1 reference

12 December 2020

Down-regulation of O6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds.

1 reference

12 December 2020

Use of temozolomide in aggressive pituitary tumors: case report

1 reference

12 December 2020

Malignant pituitary tumours

1 reference

12 December 2020

Current and future developments in the use of temozolomide for the treatment of brain tumours

1 reference

12 December 2020

Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy

1 reference

12 December 2020

Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonists

1 reference

12 December 2020

MGMT methylation: a marker of response to temozolomide in low-grade gliomas.

1 reference

12 December 2020

Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells

1 reference

12 December 2020

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors

1 reference

12 December 2020

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

12 December 2020

Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker

1 reference

12 December 2020

Treatment of pituitary neoplasms with temozolomide: a review.

1 reference

12 December 2020

Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8.

1 reference

12 December 2020

MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer

1 reference

12 December 2020

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia

1 reference

12 December 2020

The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors

1 reference

12 December 2020

Identifiers

DOI

1 reference

23 August 2017

1 reference